Sunmax Biotechnology Co., Ltd. (TPEX: 4728)

Sunmax Biotechnology Revenue

Sunmax Biotechnology had revenue of 457.54M TWD in the quarter ending September 30, 2024, a decrease of -3.46%. This brings the company's revenue in the last twelve months to 1.74B, up 4.13% year-over-year. In the year 2023, Sunmax Biotechnology had annual revenue of 1.69B with 20.64% growth.

• Revenue (ttm): 1.74B
• Revenue Growth: +4.13%
• P/S Ratio: 8.60
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.69B	288.91M	20.64%
Dec 31, 2022	1.40B	364.41M	35.19%
Dec 31, 2021	1.04B	179.81M	21.01%
Dec 31, 2020	855.85M	261.71M	44.05%
Dec 31, 2019	594.15M	290.08M	95.40%